FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4320483166> ?p ?o ?g. }

• W4320483166 endingPage "100782" @default.
• W4320483166 startingPage "100782" @default.
• W4320483166 abstract "In 2020, the European Medicines Agency recommended testing patients for dihydropyrimidine dehydrogenase (DPD) deficiency before systemic treatment with fluoropyrimidines (FP). DPD activity testing identifies patients at elevated risk of severe FP-related toxicity (FP-TOX). The two most used methods for DPD testing are DPYD genotyping and DPD phenotyping (plasma uracil concentration). The primary objective of this study was to compare the overall frequency of overall grade ≥3 FP-TOX before and after the implementation of DPYD genotyping.Two hundred thirty Danish, primarily gastrointestinal cancer patients, were DPYD-genotyped before their first dose of FP, and blood was sampled for post hoc assessment of P-uracil. The initial dose was reduced for variant carriers. Grade ≥3 FP-TOX was registered after the first three treatment cycles of FP. The frequency of toxicity was compared to a historical cohort of 492 patients with post hoc determined DPYD genotype from a biobank.The frequency of overall grade ≥3 FP-TOX was 27% in the DPYD genotype-guided group compared to 24% in the historical cohort. In DPYD variant carriers, DPYD genotyping reduced the frequency of FP-related hospitalization from 19% to 0%. In the control group, 4.8% of DPYD variant carriers died due to FP-TOX compared to 0% in the group receiving DPYD genotype-guided dosing of FP. In the intervention group, wild-type patients with uracil ≥16 ng/ml had a higher frequency of FP-TOX than wild-type patients with uracil <16 ng/ml (55% versus 28%).We found no population-level benefit of DPYD genotyping when comparing the risk of grade ≥3 FP-TOX before and after clinical implementation. We observed no deaths or FP-related hospitalizations in patients whose FP treatment was guided by a variant DPYD genotype. The use of DPD phenotyping may add valuable information in DPYD wild-type patients." @default.
• W4320483166 created "2023-02-14" @default.
• W4320483166 creator A5023072692 @default.
• W4320483166 creator A5027286810 @default.
• W4320483166 creator A5032910531 @default.
• W4320483166 creator A5053033359 @default.
• W4320483166 creator A5055784810 @default.
• W4320483166 creator A5068848511 @default.
• W4320483166 creator A5079564960 @default.
• W4320483166 creator A5082388123 @default.
• W4320483166 creator A5083690527 @default.
• W4320483166 date "2023-02-01" @default.
• W4320483166 modified "2023-10-09" @default.
• W4320483166 title "Implementation and clinical benefit of DPYD genotyping in a Danish cancer population" @default.
• W4320483166 cites W1510315517 @default.
• W4320483166 cites W1910716144 @default.
• W4320483166 cites W1990928223 @default.
• W4320483166 cites W2146161922 @default.
• W4320483166 cites W2274849119 @default.
• W4320483166 cites W2344062967 @default.
• W4320483166 cites W2367844700 @default.
• W4320483166 cites W2415516642 @default.
• W4320483166 cites W2587155796 @default.
• W4320483166 cites W2770862842 @default.
• W4320483166 cites W2883854915 @default.
• W4320483166 cites W2896913847 @default.
• W4320483166 cites W2990707203 @default.
• W4320483166 cites W3037398505 @default.
• W4320483166 cites W3109472692 @default.
• W4320483166 cites W3129455772 @default.
• W4320483166 cites W3197043586 @default.
• W4320483166 cites W3199266876 @default.
• W4320483166 cites W3213973057 @default.
• W4320483166 cites W4200179120 @default.
• W4320483166 cites W4223566428 @default.
• W4320483166 cites W4292731273 @default.
• W4320483166 cites W4306725824 @default.
• W4320483166 doi "https://doi.org/10.1016/j.esmoop.2023.100782" @default.
• W4320483166 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36791638" @default.
• W4320483166 hasPublicationYear "2023" @default.
• W4320483166 type Work @default.
• W4320483166 citedByCount "2" @default.
• W4320483166 countsByYear W43204831662023 @default.
• W4320483166 crossrefType "journal-article" @default.
• W4320483166 hasAuthorship W4320483166A5023072692 @default.
• W4320483166 hasAuthorship W4320483166A5027286810 @default.
• W4320483166 hasAuthorship W4320483166A5032910531 @default.
• W4320483166 hasAuthorship W4320483166A5053033359 @default.
• W4320483166 hasAuthorship W4320483166A5055784810 @default.
• W4320483166 hasAuthorship W4320483166A5068848511 @default.
• W4320483166 hasAuthorship W4320483166A5079564960 @default.
• W4320483166 hasAuthorship W4320483166A5082388123 @default.
• W4320483166 hasAuthorship W4320483166A5083690527 @default.
• W4320483166 hasBestOaLocation W43204831661 @default.
• W4320483166 hasConcept C104317684 @default.
• W4320483166 hasConcept C121608353 @default.
• W4320483166 hasConcept C123321153 @default.
• W4320483166 hasConcept C126322002 @default.
• W4320483166 hasConcept C135763542 @default.
• W4320483166 hasConcept C143998085 @default.
• W4320483166 hasConcept C2778050828 @default.
• W4320483166 hasConcept C2779655350 @default.
• W4320483166 hasConcept C2780456651 @default.
• W4320483166 hasConcept C2908647359 @default.
• W4320483166 hasConcept C31467283 @default.
• W4320483166 hasConcept C54355233 @default.
• W4320483166 hasConcept C55775858 @default.
• W4320483166 hasConcept C71924100 @default.
• W4320483166 hasConcept C86803240 @default.
• W4320483166 hasConcept C90924648 @default.
• W4320483166 hasConcept C99454951 @default.
• W4320483166 hasConceptScore W4320483166C104317684 @default.
• W4320483166 hasConceptScore W4320483166C121608353 @default.
• W4320483166 hasConceptScore W4320483166C123321153 @default.
• W4320483166 hasConceptScore W4320483166C126322002 @default.
• W4320483166 hasConceptScore W4320483166C135763542 @default.
• W4320483166 hasConceptScore W4320483166C143998085 @default.
• W4320483166 hasConceptScore W4320483166C2778050828 @default.
• W4320483166 hasConceptScore W4320483166C2779655350 @default.
• W4320483166 hasConceptScore W4320483166C2780456651 @default.
• W4320483166 hasConceptScore W4320483166C2908647359 @default.
• W4320483166 hasConceptScore W4320483166C31467283 @default.
• W4320483166 hasConceptScore W4320483166C54355233 @default.
• W4320483166 hasConceptScore W4320483166C55775858 @default.
• W4320483166 hasConceptScore W4320483166C71924100 @default.
• W4320483166 hasConceptScore W4320483166C86803240 @default.
• W4320483166 hasConceptScore W4320483166C90924648 @default.
• W4320483166 hasConceptScore W4320483166C99454951 @default.
• W4320483166 hasIssue "1" @default.
• W4320483166 hasLocation W43204831661 @default.
• W4320483166 hasLocation W43204831662 @default.
• W4320483166 hasLocation W43204831663 @default.
• W4320483166 hasOpenAccess W4320483166 @default.
• W4320483166 hasPrimaryLocation W43204831661 @default.
• W4320483166 hasRelatedWork W1963790758 @default.
• W4320483166 hasRelatedWork W1993642739 @default.
• W4320483166 hasRelatedWork W2202643944 @default.
• W4320483166 hasRelatedWork W3027890807 @default.

• next